Mutations in DNMT3A, TET2, ASXL1, IDH1, and IDH2 are recurrently found in AML and contribute directly or indirectly to alterations in DNA methylation (Lindblad et al., 2017). Here, TET2 is linked to acute myeloid leukemia.